# Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction

> **NCT03355651** · NA · COMPLETED · sponsor: **OPKO Health, Inc.** · enrollment: 80 (actual)

## Conditions studied

- ACL Reconstruction

## Interventions

- **DIETARY_SUPPLEMENT:** PROGEN

## Key facts

- **NCT ID:** NCT03355651
- **Lead sponsor:** OPKO Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-09
- **Primary completion:** 2017-02-01
- **Final completion:** 2017-03-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03355651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03355651, "Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03355651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*